LivaNova (LIVN) Depreciation & Amortization (CF) (2015 - 2026)
LivaNova (LIVN) posted Depreciation & Amortization (CF) of $8.3 million for Q1 2026, up 9.86% sequentially from $7.6 million in Q4 2025, and up 29.3% YoY from $6.4 million in Q1 2025.
LivaNova (LIVN) Depreciation & Amortization (CF) (2015 - 2026) Analysis & Trends
LivaNova has reported Depreciation & Amortization (CF) for 12 years, with the latest figure at $8.3 million in Q1 2026.
- Quarterly Depreciation & Amortization (CF) rose 29.3% year-over-year to $8.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.4 million (up 57.72% YoY) and the FY2025 annual result came in at $28.6 million, up 65.95% from the prior year.
- Depreciation & Amortization (CF) grew to $8.3 million in Q1 2026 per LIVN's latest filing, from $7.6 million in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $8.3 million in Q1 2026 and troughed at $4.3 million in Q4 2024.
- A 5-year average of $6.2 million and a median of $6.4 million in 2023 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2024 and 2025: Depreciation & Amortization (CF) sank 32.97% in 2024, then jumped 77.68% in 2025.
- Over 5 years, Depreciation & Amortization (CF) stood at $6.2 million in 2022, then rose by 1.85% to $6.3 million in 2023, then tumbled by 32.97% to $4.3 million in 2024, then surged by 77.68% to $7.6 million in 2025, then advanced by 9.86% to $8.3 million in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $8.3 million, $7.6 million, and $7.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.91 Bn | 193.31 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.59 Bn | 124.11 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 73.24 Bn | 72.70 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 34.38 Bn | 32.44 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 33.96 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.08 Bn | 22.60 Bn | 684.20 Mn | 123.80 Mn |
| 10 | LivaNova | 4.29 Bn | 3.77 Bn | 273.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.75 Mn |
| Jun 30, 2026 | 8.75 Mn |
| Mar 31, 2026 | 8.30 Mn |
| Mar 31, 2026 | 8.30 Mn |
| Dec 31, 2025 | 7.56 Mn |
| Dec 31, 2025 | 7.56 Mn |
| Sep 30, 2025 | 7.72 Mn |
| Sep 30, 2025 | 7.72 Mn |
| Jun 30, 2025 | 6.87 Mn |
| Jun 30, 2025 | 6.87 Mn |
| Mar 31, 2025 | 6.42 Mn |
| Mar 31, 2025 | 6.42 Mn |
| Dec 31, 2024 | 4.25 Mn |
| Dec 31, 2024 | 4.25 Mn |
| Sep 30, 2024 | 4.35 Mn |
| Sep 30, 2024 | 4.35 Mn |
| Jun 30, 2024 | 4.29 Mn |
| Jun 30, 2024 | 4.29 Mn |
| Mar 31, 2024 | 4.33 Mn |
| Mar 31, 2024 | 4.33 Mn |